Researchers from the PharmaTox Strategic Research Initiative, School of Pharmacy at University of Oslo, are going to explore the advantages of patented fish oil formulations from Smartfish. Prenantal exposure of a certain pharmaceuticals can affect brain development and can also lead to neurotoxicity. In this project, PharmaTox will evaluate if Smartfish's formulations may act as protectants in case of neurotoxicity. The supportive effect of fish oil on brain development in foetus will also be assessed in this project. The collaboration is scheduled over a time period of four years.
Read more about NNN member Smartfish
Read more about PharmaTox
Image courtesy of Bjarne Røsjø at https://titan.uio.no. From left: Prof. Ragnhild E. Paulsen, Prof. Hedvig Nordeng and Janne S. Mathise, founder of Smartfish.
